Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention. 2023

Carla Rognoni, and Gaia Segantin, and Roberto Scarsini, and Marco Valgimigli, and Francesco Loizzi, and Francesco Costa, and Patrizio Armeni
Centre for Research on Health and Social Care Management (CERGAS), SDA Bocconi School of Management, Bocconi University, Milan, Italy.

Percutaneous coronary intervention (PCI) represents the standard treatment for ST-elevated myocardial infarction, nevertheless, mortality and heart failures are frequent. Pressure-controlled intermittent coronary sinus occlusion (PiCSO) might reduce infarct size showing better patients' outcomes. We evaluated the cost-effectiveness of PCI+PiCSO compared to PCI from the National Healthcare Service (NHS) perspective in Italy. A Markov model was developed to estimate life years (LYs), quality-adjusted life years (QALYs) and costs. A micro-costing analysis has been performed to inform the cost of PCI+PiCSO procedure. Sensitivity analyses were performed to test the robustness of the model results. Considering a willingness-to-pay threshold of 50,000€/QALY for the ICUR and a cost for PCI+PiCSO procedure of 14,654€, the innovative strategy may be cost-effective compared to PCI alone from the Italian NHS perspective, showing an ICUR of 17,530€/QALY (ICER 14,631€/LY) over a lifetime horizon; the probabilistic sensitivity analysis showed that PCI+PiCSO is cost-effective in 78.8% of simulations.Considering the above mentioned willingness-to-pay threshold, PCI+PiCSO strategy would be cost-effective over a lifetime horizon considering a cost for PCI+PiCSO procedure lower than 28,160€. PCI+PiCSO procedure may be considered a cost-effective technology that allows reducing cardiac events, while improving patients' life expectancy and quality of life.

UI MeSH Term Description Entries
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000094703 Cost-Effectiveness Analysis A method of comparing the cost of a program with its expected outcomes that are qualitative in nature. Cost effectiveness compares alternative ways to achieve a specific set of results. Cost Effectiveness,Cost Effectiveness Ratio,Analysis, Cost-Effectiveness,Cost Effectiveness Analysis,Cost Effectiveness Ratios,Effectiveness Ratio, Cost,Effectiveness, Cost,Ratio, Cost Effectiveness
D054326 Coronary Sinus A short vein that collects about two thirds of the venous blood from the MYOCARDIUM and drains into the RIGHT ATRIUM. Coronary sinus, normally located between the LEFT ATRIUM and LEFT VENTRICLE on the posterior surface of the heart, can serve as an anatomical reference for cardiac procedures. Sinus, Coronary
D062645 Percutaneous Coronary Intervention A family of percutaneous techniques that are used to manage CORONARY OCCLUSION, including standard balloon angioplasty (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY), the placement of intracoronary STENTS, and atheroablative technologies (e.g., ATHERECTOMY; ENDARTERECTOMY; THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY). PTCA was the dominant form of PCI, before the widespread use of stenting. Percutaneous Coronary Revascularization,Coronary Intervention, Percutaneous,Coronary Interventions, Percutaneous,Coronary Revascularization, Percutaneous,Coronary Revascularizations, Percutaneous,Intervention, Percutaneous Coronary,Interventions, Percutaneous Coronary,Percutaneous Coronary Interventions,Percutaneous Coronary Revascularizations,Revascularization, Percutaneous Coronary,Revascularizations, Percutaneous Coronary
D019057 Quality-Adjusted Life Years A measurement index derived from a modification of standard life-table procedures and designed to take account of the quality as well as the duration of survival. This index can be used in assessing the outcome of health care procedures or services. (BIOETHICS Thesaurus, 1994) Adjusted Life Year,Healthy Years Equivalent,QALYs,QUALYs,Quality Adjusted Life Year,Quality-Adjusted Life Year,Adjusted Life Years,Healthy Years Equivalents,Quality Adjusted Life Years,Equivalents, Healthy Years,Life Year, Adjusted,Life Year, Quality-Adjusted,Life Years, Adjusted,Life Years, Quality-Adjusted,QUALY,Years, Adjusted Life

Related Publications

Carla Rognoni, and Gaia Segantin, and Roberto Scarsini, and Marco Valgimigli, and Francesco Loizzi, and Francesco Costa, and Patrizio Armeni
December 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,
Carla Rognoni, and Gaia Segantin, and Roberto Scarsini, and Marco Valgimigli, and Francesco Loizzi, and Francesco Costa, and Patrizio Armeni
June 1985, The Surgical clinics of North America,
Carla Rognoni, and Gaia Segantin, and Roberto Scarsini, and Marco Valgimigli, and Francesco Loizzi, and Francesco Costa, and Patrizio Armeni
August 1988, The Annals of thoracic surgery,
Carla Rognoni, and Gaia Segantin, and Roberto Scarsini, and Marco Valgimigli, and Francesco Loizzi, and Francesco Costa, and Patrizio Armeni
January 2001, The Annals of thoracic surgery,
Carla Rognoni, and Gaia Segantin, and Roberto Scarsini, and Marco Valgimigli, and Francesco Loizzi, and Francesco Costa, and Patrizio Armeni
January 1989, Biomedical instrumentation & technology,
Carla Rognoni, and Gaia Segantin, and Roberto Scarsini, and Marco Valgimigli, and Francesco Loizzi, and Francesco Costa, and Patrizio Armeni
March 1984, The American journal of cardiology,
Carla Rognoni, and Gaia Segantin, and Roberto Scarsini, and Marco Valgimigli, and Francesco Loizzi, and Francesco Costa, and Patrizio Armeni
March 1989, The American journal of physiology,
Carla Rognoni, and Gaia Segantin, and Roberto Scarsini, and Marco Valgimigli, and Francesco Loizzi, and Francesco Costa, and Patrizio Armeni
March 2001, Scandinavian cardiovascular journal : SCJ,
Carla Rognoni, and Gaia Segantin, and Roberto Scarsini, and Marco Valgimigli, and Francesco Loizzi, and Francesco Costa, and Patrizio Armeni
April 1985, Journal of the American College of Cardiology,
Carla Rognoni, and Gaia Segantin, and Roberto Scarsini, and Marco Valgimigli, and Francesco Loizzi, and Francesco Costa, and Patrizio Armeni
August 1988, The Annals of thoracic surgery,
Copied contents to your clipboard!